Insys Therapeutics, Inc. (NASDAQ:INSY) (“Insys” or “the Company”) today announced that the Company has enrolled the first patient in a Phase II clinical study for the treatment of infantile spasms (IS) using its pharmaceutical CBD (CBD) product candidate.
Category Archives: AZBio News
UA College of Medicine – Phoenix Granted Provisional Accreditation
Approval is the next step to full accreditation for the medical school
Arizona Senate Proclamation Recognizes the Work of our Bioscience Community
Arizona Senator Nancy Barto, Chairman of the Health and Human Services Committee reads the Senate Proclamation recognizing the work of Arizona’s Bioindustry and proclaiming the week of September 18, 2016 as Arizona Bioscience Week.Continue reading
US EDA Awards $250K Grant to BioAccel for the Southwest Integrated Investment Ecosystem Development Project
BIOACCEL ANNOUNCES MAJOR FUNDING FROM ECONOMIC DEVELOPMENT ADMINISTRATION FOR DEVELOPING EARLY-STAGE INVESTMENT ECOSYSTEM IN ARIZONA AND SOUTHWESTERN U.S. Continue reading
ASU’s Dr. Qiang Chen on what to expect from the latest global health concern
Qiang “Shawn” Chenis an ASU Biodesign Institute researcher and School of Life School Sciences professor, Center for Infectious Diseases and Vaccinology.
ARIZONA INNOVATION CHALLENGE – Spring 2016
The ARIZONA INNOVATION CHALLENGE (AIC) Spring 2016 Round Opens Monday February 8,2016. Up to 6 Companies will Win Up to $250,000 each.Continue reading
HB 2310- Getting Ready for Biosimilars in Arizona
The FDA approved the first biosimilar in the U.S. in March of 2015 with more expected to be approved in 2016. Now, on a state by state basis, the laws that govern how these new therapies can be dispensed are being updated. Arizona has the opportunity to do so in 2016 with HB 2310 sponsored by Dr. Regina Cobb, Vice Chairman of the House Health Committee.Continue reading
Flagship Biosciences Creates Clinical Trials and Regulatory Affairs Group
Flagship Biosciences created a Clinical Trials and Regulatory Affairs Group and partners with DOCRO, Inc., an industry leader for IVD clinical trials and regulatory affairs, to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Continue reading
Cancer Moon Shot 2020
Historic National Coalition formed to accelerate next generation immunotherapy in cancer careContinue reading
ASU names LaBaer interim executive director of the Biodesign Institute
Dr. Joshua L. LaBaer, named interim executive director for the Biodesign Institute at Arizona State University.